'Organoids' can help pinpoint the right therapies for cancer patients Precision medicine, using the power of the human genome to diagnose and treat patients, is about to get even more precise. Jun 22, 2020 0 3
Immune cells infiltrating tumors may play bigger cancer role than previously thought Most traditional cancer therapies target either the tumor cells themselves or indiscriminately kill any rapidly dividing cell. New findings by researchers at University of California San Diego School of Medicine indicate ... Jun 22, 2020 0 206
UN: Pandemic appears to be peaking in several big countries A record level of new daily COVID-19 cases worldwide could suggest the pandemic is peaking in some large countries, even as the coronavirus has become "well established" in some regions, the World Health Organization's emergencies ... Jun 22, 2020 1 1
New class of precision medicine strips cancer of its DNA defenses A new precision medicine targeting cancer's ability to repair its DNA has shown promising results in the first clinical trial of the drug class. Jun 22, 2020 0 1108
Brazilian scientists develop COVID-19 accelerometer Researchers at São Paulo State University (UNESP) in Araçatuba, Brazil, have developed a computational tool that acts like a "COVID-19 accelerometer," plotting in real time the rate at which growth is accelerating or decelerating ... Jun 22, 2020 0 2
Scientists confirm usually harmless virus attacks the heart's electrical system Virginia Tech researchers studying how a usually benign virus attacks the human heart with sometimes fatal consequences determined that the virus disrupts the heart's electrical system—and with dual impacts not previously ... Jun 22, 2020 0 484
Mouse model identified to study common form of heart failure linked to age-related obesity A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical ... Jun 22, 2020 0 30
Initial COVID-19 infection rate may be 80 times greater than originally reported Many epidemiologists believe that the initial COVID-19 infection rate was undercounted due to testing issues, asymptomatic and alternatively symptomatic individuals, and a failure to identify early cases. Jun 22, 2020 1 4068
Inhaled remdesivir may allow COVID-19 patients to be treated at home (HealthDay)—An inhaled version of the antiviral drug remdesivir will soon be tested outside a hospital setting, Gilead Sciences announced Monday. Jun 22, 2020 0 36
Citing lack of benefit, NIH halts trial of hydroxychloroquine for COVID-19 (HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long supported by President Donald Trump as a possible panacea for COVID-19. Jun 22, 2020 0 2
